skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Immunotherapeutic GSK1572932A (Code C91714)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Immunotherapeutic GSK1572932A

Definition: An immunotherapeutic containing a proprietary adjuvant system combined with a melanoma-associated antigen peptide MAGE-A3 epitope with potential immunomodulating and antineoplastic activities. Intramuscular administration with GSK1572932A may stimulate the immune system to exert both humoral and cellular immune responses against MAGE-A3-expressing tumor cells. MAGE-A3, a tumor associated antigen (TAA), is overexpressed in a variety of tumor cell types, including non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, and bladder cancer.

Display Name: Immunotherapeutic GSK1572932A

Label: Immunotherapeutic GSK1572932A

NCI Thesaurus Code: C91714 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL371862  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Immunotherapeutic GSK1572932A

External Source Codes: 
PDQ Closed Trial Search ID 544201
PDQ Open Trial Search ID 544201 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C91714
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom